Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
07/1992
07/07/1992US5128327 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
06/1992
06/30/1992US5126452 Optically active stereoisomers
06/30/1992US5126347 Autoimmune deficiency syndrome
06/30/1992US5126345 Viricides
06/30/1992CA1304365C Oxetanocins
06/25/1992WO1992010497A1 ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES
06/25/1992WO1992010496A1 ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES
06/25/1992CA2590125A1 Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
06/24/1992EP0490967A1 Process for preparing 3,7-dialkyl xanthines
06/24/1992CN1062138A Synergism of hiv reverse transcriptase inhibitors
06/24/1992CN1017153B Purine-substituted oxygen heterocycle butane
06/22/1992WO1992011260A1 Xanthine derivatives
06/22/1992CA2098846A1 Xanthine derivatives
06/21/1992CA2055129A1 Cam-lock busway joint assembly
06/17/1992EP0490181A1 Use of xanthines for preparation of a medicament having immunosuppressing activity
06/17/1992EP0489876A1 Synthesis of cyclopentene derivatives
06/17/1992CN1061972A Process for preparing hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
06/11/1992WO1992009604A1 6-azido-2-fluoropurine
06/09/1992US5120747 Platelet activating factor antagonists
06/09/1992US5120740 Targeting antitumor drugs to kidneys
06/09/1992CA1303037C Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
06/03/1992EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same
06/03/1992EP0488079A1 Oxadiazolylmethylpurines, their preparation, and their pharmaceutical use
06/03/1992EP0487694A1 Oligonucleotide functionalization method
06/03/1992EP0487673A1 New xanthine derivatives
06/03/1992EP0487658A1 Synthesis of purine substituted cyclopentene derivatives
06/03/1992EP0487657A1 Process for the synthesis of cyclopentene derivatives
06/03/1992CN1061600A Chemical process
06/02/1992US5118808 Pharmaceutical preparations
06/02/1992US5118689 Antiarrhythmia agents
06/02/1992US5118500 Side effect reduction when administering a xanthine derivative
06/02/1992CA1302410C Dihydropyridine anti-allergic and anti-inflammatory agents
05/1992
05/31/1992CA2056800A1 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
05/31/1992CA2056723A1 Use of xanthines for the preparation of a medicament having immuno supressing activity
05/29/1992WO1992008717A1 Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
05/26/1992CA1301755C Process for recovering caffeine adsorbed to activated carbon
05/26/1992CA1301754C Process for recovering caffeine absorbed in activated carbon, and a process for decaffeinating coffee
05/23/1992CA2055946A1 Chemical process
05/22/1992WO1992009203A1 Tnf inhibitors
05/22/1992CA2096623A1 Tnf inhibitors
05/14/1992WO1992007852A1 Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
05/13/1992EP0485156A1 Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes
05/13/1992EP0484785A2 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses
05/12/1992US5112844 Micelles
05/12/1992CA1300622C Anti-viral compounds
05/08/1992CA2055041A1 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses
05/06/1992EP0484071A2 Synergism of HIV reverse transcriptase inhibitors
05/06/1992EP0483985A1 Fungicides
05/06/1992CN1060842A Cyelobutane derivatives
05/05/1992US5110929 Quaternization of pyrazine compounds
05/05/1992US5110926 Carbocyclic guanosine
05/05/1992US5110818 Antiepileptic agents
05/02/1992CA2054529A1 Synergism of hiv reverse transcriptase inhibitors
04/1992
04/29/1992EP0482493A2 Pharmaceutical compositions active in the therapy of neurological affections in aids patients, containing as an active principle at last one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid, 5-formyltetrahydrofolic acid
04/28/1992US5109003 Method for the treatment of peptic ulcer disease
04/23/1992DE4031601A1 New bi:phenyl:methyl-substd. imidazole derivs.
04/22/1992EP0481754A2 Hydroxymethyl(methylenecyclopentyl)Purines and Pyrimidines
04/22/1992EP0481320A1 Novel cyclobutane derivatives
04/19/1992WO1992006976A1 Xanthine derivative
04/18/1992WO1992006977A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
04/18/1992CA2071911A1 P-substituted derivatives of phenyl 4-oxybutane amine, processes for preparation thereof, and pharmaceutical compositions holding same
04/16/1992WO1992006086A1 Novel 4-piperidinylcarbonyl derivatives
04/15/1992EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia
04/15/1992EP0480204A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor
04/15/1992EP0479822A1 Therapeutic nucleosides
04/14/1992USRE33887 Anti-retroviral compounds
04/14/1992US5104443 Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators
04/10/1992CA2052315A1 Cyclobutane derivatives
04/08/1992EP0478628A1 Pyrrol derivates, their preparation and their use as interceptors of activated dioxygen
04/07/1992US5102880 Biphenyl imidazotriazine derivatives; Hypotensive and cardiotonic agents
04/07/1992US5102443 Heterocyclically substituted phenoxysulfonylureas, and the use thereof as herbicides or plant growth regulators
04/03/1992WO1992006102A1 Nucleoside derivatives
04/03/1992CA2093020A1 Nucleoside derivatives
04/02/1992WO1992005180A1 Heterocyclic compounds
04/02/1992WO1992005177A1 Compounds having antihypertensive and anti-ischemic properties
04/01/1992EP0477700A1 6'-C-alkyl- or alkynyl-neplanocin A, and its preparation process and use
04/01/1992CN1059909A Carbocyclic adenosine analogs useful as immunosuppressants
03/1992
03/27/1992WO1992005176A1 Xanthines
03/27/1992WO1992005175A1 Xanthine derivatives
03/27/1992CA2092430A1 Xanthine derivatives
03/27/1992CA2092429A1 Xanthines
03/26/1992CA2052125A1 Heterocyclic derivatives
03/24/1992US5098996 Process for introducing fluorine into biologically active materials
03/24/1992US5098906 Autoimmune disease treatment, antiinflammatory agents and viricides
03/24/1992US5098805 Nondiscoloring photographic films
03/18/1992EP0475413A2 Carbocyclic nucleoside analogs useful as immunosuppressants
03/18/1992EP0475411A1 Novel carbocyclic adenosine analogs useful as immunosuppressants
03/18/1992CN1059528A Carbocyclic analogs of certain nucleosides
03/18/1992CN1059524A Nucleic acid derivatives
03/17/1992US5097097 Triazinylaminofluoresceins
03/11/1992WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
03/11/1992CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity
03/10/1992CA1297021C Therapeutic agent for the treatment of peptic ulcer disease
03/04/1992EP0472663A1 Method of treatment of hepatitis
03/03/1992US5093318 Immunostimulating guanosine derivatives and their pharmaceutical compositions
03/03/1992CA1296726C 9-hydroxyalkoxyguanines
02/1992
02/25/1992US5091519 Nucleotide compositions with linking groups
02/25/1992US5091432 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
02/25/1992US5091431 Phosphodiesterase inhibitors
02/20/1992WO1992002516A1 Process for producing 2',3'-dideoxy-2',3'-didehydronucleoside